BMO Capital Downgrades Ambit Biosciences (AMBI) to Market Perform
Tweet
Share
E-mailGet Alerts AMBI Hot Sheet
Price: $0.54 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
BMO Capital downgraded Ambit Biosciences (NASDAQ: AMBI) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Ambit Biosciences click here. For more ratings news on Ambit Biosciences click here.
Shares of Ambit Biosciences closed at $8.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
- UBS Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
- Freedom Broker Downgrades Holley (HLLY) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
